Parent-of-origin effects at the major histocompatibility complex in multiple sclerosis

Human Molecular Genetics

Volumn 19, Issue 18, 2010, Pages 3679-3689

  Chao, Michael J ^a,b   Herrera, Blanca M ^a,b   Ramagopalan, Sreeram V ^a   Deluca, Gabriel ^a,b   Handunetthi, Lahiru ^a,b   Orton, Sarah M ^a,b   Lincoln, Matthew R ^a,b   Dessa Sadovnick, A ^c   Ebers, George C ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ARTICLE; AUTOIMMUNITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA MODIFICATION; EPIGENETICS; FEMALE; GENE TRANSFER; GENETIC EPISTASIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROGENY; SEX RATIO;

COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOMIC IMPRINTING; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; MALE; MULTIPLE SCLEROSIS; PEDIGREE;

EID: 77956144407     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq282     Document Type: Article

References (53)

1. Noseworthy, J.H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B.G. (2000) Multiple sclerosis. N. Engl. J. Med., 343, 938-952.
2. Keegan, B.M. and Noseworthy, J.H. (2002) Multiple sclerosis. Annu. Rev. Med., 53, 285-302.
3. Ebers, G.C. (2008) Environmental factors and multiple sclerosis. Lancet Neurol., 7, 268-277.
4. Ebers, G.C. and Dyment, D.A. (1998) Genetics of multiple sclerosis. Semin. Neurol., 18, 295-299.
5. Lincoln, M.R., Montpetit, A., Cader, M.Z., Saarela, J., Dyment, D.A., Tiislar, M., Ferretti, V., Tienari, P.J., Sadovnick, A.D., Peltonen, L. et al. (2005) A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat. Genet., 37, 1108-1112.
6. Lincoln, M.R., Ramagopalan, S.V., Chao, M.J., Herrera, B.M., Deluca, G.C., Orton, S.M., Dyment, D.A., Sadovnick, A.D. and Ebers, G.C. (2009) Epistasis among HLA-DRB1, HLA-DQA1 and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc. Natl Acad. Sci. USA, 106, 7542-7547.
7. Ramagopalan, S.V. and Ebers, G.C. (2009) Epistasis: multiple sclerosis and the major histocompatibility complex. Neurology, 72, 566-567.
8. Andersson, G. (1998) Evolution of the human HLA-DR region. Front Biosci., 3, d739-d745.
9. Raymond, C.K., Kas, A., Paddock, M., Qiu, R., Zhou, Y., Subramanian, S., Chang, J., Palmieri, A., Haugen, E., Kaul, R. et al. (2005) Ancient haplotypes of the HLA Class II region. Genome Res., 15, 1250-1257.
10. Bergstrom, T.F., Josefsson, A., Erlich, H.A. and Gyllensten, U. (1998) Recent origin of HLA-DRB1 alleles and implications for human evolution. Nat. Genet., 18, 237-242.
11. Svensson, A.C., Setterblad, N., Pihlgren, U., Rask, L. and Andersson, G. (1996) Evolutionary relationship between human major histocompatibility complex HLA-DR haplotypes. Immunogenetics, 43, 304-314.
12. Chao, M.J., Ramagopalan, S.V., Herrera, B.M., Lincoln, M.R., Dyment, D.A., Sadovnick, A.D. and Ebers, G.C. (2009) Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum. Mol. Genet., 18, 261-266.
13. Ligers, A., Dyment, D.A., Willer, C.J., Sadovnick, A.D., Ebers, G., Risch, N. and Hillert, J. (2001) Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis. Am. J. Hum. Genet., 69, 900-903.
14. Barcellos, L.F., Sawcer, S., Ramsay, P.P., Baranzini, S.E., Thomson, G., Briggs, F., Cree, B.C., Begovich, A.B., Villoslada, P., Montalban, X. et al. (2006) Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum. Mol. Genet., 15, 2813-2824.
15. Dyment, D.A., Herrera, B.M., Cader, M.Z., Willer, C.J., Lincoln, M.R., Sadovnick, A.D., Risch, N. and Ebers, G.C. (2005) Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum. Mol. Genet., 14, 2019-2026.
16. Ramagopalan, S.V., Morris, A.P., Dyment, D.A., Herrera, B.M., DeLuca, G.C., Lincoln, M.R., Orton, S.M., Chao, M.J., Sadovnick, A.D. and Ebers, G.C. (2007) The inheritance of resistance alleles in multiple sclerosis. PLoS Genet., 3, 1607-1613.
17. Roth, M.P., Clayton, J., Patois, E. and Alperovitch, A. (1994) Gender distributions in parents and children concordant for multiple sclerosis. Neuroepidemiology, 13, 211-215.
18. Sadovnick, A.D., Bulman, D. and Ebers, G.C. (1991) Parent-child concordance in multiple sclerosis. Ann. Neurol., 29, 252-255.
19. Sadovnick, A.D., Yee, I.M. and Ebers, G.C. (2000) Factors influencing sib risks for multiple sclerosis. Clin. Genet., 58, 431-435.
20. Ebers, G.C., Sadovnick, A.D., Dyment, D.A., Yee, I.M., Willer, C.J. and Risch, N. (2004) Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet, 363, 1773-1774.
21. Herrera, B.M., Ramagopalan, S.V., Lincoln, M.R., Orton, S.M., Chao, M.J., Sadovnick, A.D. and Ebers, G.C. (2008) Parent-of-origin effects in MS: observations from avuncular pairs. Neurology, 71, 799-803.
22. Celius, E.G., Harbo, H.F., Egeland, T., Vartdal, F., Vandvik, B. and Spurkiand, A. (2000) Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J. Neurol. Sci., 178, 132-135.
23. Dyment, D.A., Ebers, G.C. and Sadovnick, A.D. (2004) Genetics of multiple sclerosis. Lancet Neurol., 3, 104-110.
24. Orton, S.M., Herrera, B.M., Yee, I.M., Valdar, W., Ramagopalan, S.V., Sadovnick, A.D. and Ebers, G.C. (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol., 5, 932-936.
25. Murray, S., Bashir,K., Penrice, G. andWomersley, S.J. (2004) Epidemiology of multiple sclerosis in Glasgow. Scott. Med. J., 49, 100-104.
26. Rothwell, P.M. and Charlton, D. (1998) High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J. Neurol. Neurosurg. Psychiatr., 64, 730-735.
27. Willer, C.J., Dyment, D.A., Risch, N.J., Sadovnick, A.D. and Ebers, G.C. (2003) Twin concordance and sibling recurrence rates in multiple sclerosis. Proc. Natl Acad. Sci. USA, 100, 12877-12882.
28. Van Lambalgen, R., Sanders, E.A. and D'Amaro, J. (1986) Sex distribution, age of onset and HLA profiles in two types of multiple sclerosis. A role for sex hormones and microbial infections in the development of autoimmunity? J. Neurol. Sci., 76, 13-21.
29. *15 in multiple sclerosis. Hum. Genet., 122, 661-663.
30. Trapp, B.D. and Stys, P.K. (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol., 8, 280-291.
31. Tsutsui, S. and Stys, P.K. (2009) Degeneration versus autoimmunity in multiple sclerosis. Ann. Neurol., 66, 711-713.
32. Beeson, P.B. (1994) Age and sex associations of 40 autoimmune diseases. Am. J. Med., 96, 457-462.
33. Gregory, S.G., Schmidt, S., Seth, P., Oksenberg, J.R., Hart, J., Prokop, A., Caillier, S.J., Ban, M., Goris, A., Barcellos, L.F. et al. (2007) Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet., 39, 1083-1091.
34. Lundmark, F., Duvefelt, K., Iacobaeus, E., Kockum, I., Wallstrom, E., Khademi, M., Oturai, A., Ryder, L.P., Saarela, J., Harbo, H.F. et al. (2007) Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet., 39, 1108-1113.
35. Chao, M.J., Barnardo, M.C., Lincoln, M.R., Ramagopalan, S.V., Herrera, B.M., Dyment, D.A., Montpetit, A., Sadovnick, A.D., Knight, J.C. and Ebers, G.C. (2008) HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc. Natl Acad. Sci. USA, 105, 13069-13074.
36. Ramagopalan, S.V., McMahon, R., Dyment, D.A., Sadovnick, A.D., Ebers, G.C. and Wittkowski, K.M. (2009) An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene. BMC Med. Genet., 10, 10.
37. Rassoulzadegan, M., Grandjean, V., Gounon, P., Vincent, S., Gillot, I. and Cuzin, F. (2006) RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse. Nature, 441, 469-474.
38. Teixeira, F.K., Heredia, F., Sarazin, A., Roudier, F., Boccara, M., Ciaudo, C., Cruaud, C., Poulain, J., Berdasco, M., Fraga, M.F. et al. (2009) A role for RNAi in the selective correction of DNA methylation defects. Science, 323, 1600-1604.
39. Kwon, O.J., Karni, A., Israel, S., Brautbar, C., Amar, A., Meiner, Z., Abramsky, O. and Karussis, D. (1999) HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch. Neurol., 56, 555-560.
40. Marrosu, M.G., Murru, M.R., Costa, G., Cucca, F., Sotgiu, S., Rosati, G. and Muntoni, F. (1997) Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am. J. Hum. Genet., 61, 454-457.
41. Marrosu, M.G., Sardu, C., Cocco, E., Costa, G., Murru, M.R., Mancosu, C., Murru, R., Lai, M. and Contu, P. (2004) Bias in parental transmission of the HLA-DR3 allele in Sardinian multiple sclerosis. Neurology, 63, 1084-1086.
42. Vige, A., Gallou-Kabani, C. and Junien, C. (2008) Sexual dimorphism in non-Mendelian inheritance. Pediatr. Res., 63, 340-347.
43. Ramagopalan, S.V., Maugeri, N.J., Handunnetthi, L., Lincoln, M.R., Orton, S.M., Dyment, D.A., Deluca, G.C., Herrera, B.M., Chao, M.J., Sadovnick, A.D. et al. (2009) Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet., 5, e1000369.
44. Pembrey, M.E. (2002) Time to take epigenetic inheritance seriously. Eur. J. Hum. Genet., 10, 669-671.
45. Whitacre, C.C. (2001) Sex differences in autoimmune disease. Nat. Immunol., 2, 777-780.
46. Willer, C.J., Dyment, D.A., Sadovnick, A.D., Rothwell, P.M., Murray, T.J. and Ebers, G.C. (2005) Timing of birth and risk of multiple sclerosis: population based study. Br. Med. J., 330, 120.
47. Ramagopalan, S.V., Link, J., Byrnes, J.K., Dyment, D.A., Giovannoni, G., Hintzen, R.Q., Sundqvist, E., Kockum, I., Smestad, C., Lie, B.A. et al. (2009) HLA-DRB1 and month of birth in multiple sclerosis. Neurology, 73, 2107-2111.
48. Yagi, S., Hirabayashi, K., Sato, S., Li, W., Takahashi, Y., Hirakawa, T., Wu, G., Hattori, N., Ohgane, J., Tanaka, S. et al. (2008) DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) in mouse promoter regions demonstrating tissue-specific gene expression. Genome Res., 18, 1969-1978.
49. Sadovnick, A.D., Risch, N.J. and Ebers, G.C. (1998) Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can. J. Neurol. Sci., 25, 216-221.
50. O'Connell, J.R. and Weeks, D.E. (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet., 63, 259-266.
51. Dudbridge, F. (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol., 25, 115-121.
52. Cordell, H.J. and Clayton, D.G. (2002) A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am. J. Hum. Genet., 70, 124-141.
53. Cordell, H.J., Barratt, B.J. and Clayton, D.G. (2004) Case/pseudocontrol analysis in genetic association studies: a unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects. Genet. Epidemiol., 26, 167-185.